Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Nanopharmaceutics, Inc.Startup |
Active Organization Nanopharmaceutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Phase 2 | US | Nanopharmaceutics, Inc.Startup | 25 Apr 2023 |